Novartis India Limited (NSE:NOVARTIND)

Market Cap	25.94B +33.7%
Revenue (ttm)	3.48B -1.7%
Net Income	972.30M +12.7%
EPS	39.38 +12.7%
Shares Out	n/a
PE Ratio	26.68
Forward PE	n/a
Dividend	25.00 (2.41%)
Ex-Dividend Date	Jul 23, 2025

Volume	8,994
Average Volume	12,002
Open	1,051.40
Previous Close	1,036.60
Day's Range	1,036.60 - 1,054.20
52-Week Range	950.00 - 1,059.90
Beta	0.43
RSI	n/a
Earnings Date	n/a

About Novartis India

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 56
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NOVARTIND

Financial Performance

In fiscal year 2025, Novartis India's revenue was 3.56 billion, an increase of 6.33% compared to the previous year's 3.35 billion. Earnings were 1.01 billion, an increase of 18.44%.